CYTK — Cytokinetics Incorporated stock price and chart

CYTK

$56.13-0.05%

as of close, Nov 13, 2026

☾ AH $56.13 -0.05%

Cytokinetics IncorporatedStock · HealthcareRussell 2000 · 0.3% of IWMNasdaq Composite · 0.02% of ONEQUS Stock Market · 0.02% of VTIRussell 3000 · 0.02% of IWV

PeersASNDALNYAXSMSPYQQQNVDA

Share this page

Head-to-head:Compare with ASND or any ticker →

Technical analysis2

Overlay lines0

Addendum charts0

Volume11.3M

EEEEEEEEEEEEEEEEEEEEEE

2017201820192020202120222023202420252026

0.010.020.030.040.050.060.070.080.090.0050.0M100.0M$56.13

2026-11-13

Price$56.13

MA20$71.01

MA50$66.55

Vol11.3M

Data provided bySource: Twelve Data

What would $1,000 invested in CYTK be worth today? →

CYTK returns: By year · By month · By week · Trailing

Key stats#

Data provided bySource: Twelve Data

Price data

Price: $56.13
YTD price return: -11.66%
YTD total return: -11.66%
Market cap: 7.8B2016-12 492.3M2026-11 7.8B+1488.6% over the window
Enterprise value: 6.8B
Shares outstanding: 139.3M2016-09 40.5M2026-09 139.3M+243.8% over the window
52W low: $53.55
52W high: $88.31
From 52W high: -36.44%
From 52W low: +4.82%
52W range: 7%$53.55–$88.31
Beta: 0.37

Volume

Rel volume: 0.50×
30D volume: 2M
30D $ vol: 121.4M

Insider trading

Insider net 1W0 insider-days of buying (no priced lot) and 1 of selling ($274K) in the last 7 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$274K
Insider net 1M0 insider-days of buying (no priced lot) and 4 of selling ($1.2M) in the last 30 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$1.2M
Insider net 3M0 insider-days of buying (no priced lot) and 17 of selling ($12.2M) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$12.2M
Insider net 1Y0 insider-days of buying (no priced lot) and 67 of selling ($43.7M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$43.7M

Form 4 transactions by trade date, as filed; latest on file 2026-11-09.

Fundamentals

Sales (ttm): 113.3M2016-09 83M2026-09 113.3M+36.5% over the window
Sales/share: $0.812016-09 $2.052026-09 $0.81-60.3% over the window
EPS (ttm): -$6.022016-09 $0.002026-09 -$6.02-388413.5% over the window
FCF (ttm): -588.6M2016-09 -51.7M2026-09 -588.6M+1037.7% over the window
FCF/share: -$4.232016-09 -$1.282026-09 -$4.23+230.9% over the window
Book value/share: -$2.312016-09 $2.092026-09 -$2.31-210.3% over the window
Net margin: -686.63%2016-09 0.1%2026-09 -686.6%-850981.3% over the window
ROA: -42.63%2016-09 0.0%2026-09 -42.6%-100737.2% over the window
Current ratio: 3.362016-09 5.322026-09 3.36-36.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +29.93%2025-09-30 → 2026-09-3087.2M → 113.3M (+29.9% total)+143.78%2023-09-30 → 2026-09-307.8M → 113.3M (+1349.7% total)+39.37%2021-09-30 → 2026-09-3021.6M → 113.3M (+425.7% total)+3.16%2016-09-30 → 2026-09-3083M → 113.3M (+36.5% total)
Shares: +13.95%2025-09-30 → 2026-09-30122.3M → 139.3M (+13.9% total)+12.41%2023-09-30 → 2026-09-3098.1M → 139.3M (+42.1% total)+11.64%2021-09-30 → 2026-09-3080.3M → 139.3M (+73.4% total)+13.15%2016-09-30 → 2026-09-3040.5M → 139.3M (+243.8% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +14.03%2025-09-30 → 2026-09-30$0.71 → $0.81 (+14.0% total)+116.86%2023-09-30 → 2026-09-30$0.08 → $0.81 (+920.4% total)+24.84%2021-09-30 → 2026-09-30$0.27 → $0.81 (+203.2% total)-8.83%2016-09-30 → 2026-09-30$2.05 → $0.81 (-60.3% total)
Price: -14.34%2025-11-13 → 2026-11-13$65.52 → $56.13 (-14.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+20.58%2023-11-13 → 2026-11-13$32.01 → $56.13 (+75.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+7.45%2021-11-12 → 2026-11-13$39.19 → $56.13 (+43.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+17.48%2016-11-11 → 2026-11-13$11.20 → $56.13 (+401.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -14.34%2025-11-13 → 2026-11-13$65.52 → $56.13 (-14.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+20.58%2023-11-13 → 2026-11-13$32.01 → $56.13 (+75.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+7.45%2021-11-12 → 2026-11-13$39.19 → $56.13 (+43.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+17.48%2016-11-11 → 2026-11-13$11.20 → $56.13 (+401.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -9.3×2016-12 7347.472026-11 -10.05-100.1% over the window
Fwd P/E: -13.8×
P/S (ttm)Market cap ÷ TTM revenue.: 69.0×2016-12 5.932026-11 69.03+1064.2% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: -24.3×2016-12 5.812026-11 -24.35-519.1% over the window
EV/Sales (ttm): 59.7×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -7.53%2016-09 -10.5%2026-09 -6.4%-39.0% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-09-30) ÷ shares_at(2025-09-30) = 1 − 139.3M ÷ 122.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -13.95%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-13.95%) + dividends paid over that year ($0) ÷ market_cap_at(2025-09-30) ($6.7B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -13.95%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-760.1M) ÷ today's market cap ($7.8B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -9.72%2016-09 -1.8%2026-09 -8.3%+369.9% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-760.1M + TTM dividends $0) ÷ today's market cap ($7.8B). Same caveat as the cash buyback yield.: -9.72%2016-09 -1.8%2026-09 -8.3%+369.9% over the window

Vs own 10Y history

P/S: 63rd
P/B: 85th

Bar = where today’s multiple sits in CYTK’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-13#

Data provided bySource: Twelve Data

-0.05%

+4.54%

-8.91%

-23.58%

YTD

-11.66%

-14.33%

+43.23%

-0.05%

+4.54%

-8.91%

-23.58%

YTD

-11.66%

-14.33%

+43.23%